Flurbiprofen and HCT1026 protect mice against acute pancreatitis-associated lung injury

Shock

Volumn 24, Issue 2, 2005, Pages 182-187

  Huang, Jiali ^a   Moochhala, Shabbir M ^a,b   Moore, Philip K ^a   Bhatia, Madhav ^a,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DSO NATIONAL LABORATORIES   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cerulein; Cyclooxygenase; Inflammation; Myeloperoxidase

Indexed keywords

AMYLASE; CERULETIDE; FLURBIPROFEN; FLURBIPROFEN 4 NITROXYBUTYL ESTER; MYELOPEROXIDASE; NITROGEN OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

ACINAR CELL; ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM INJURY; DISEASE ASSOCIATION; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; HISTOPATHOLOGY; HYPERAMYLASEMIA; LUNG INJURY; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PANCREAS NECROSIS; PROPHYLAXIS;

ACUTE DISEASE; AMYLASES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FLURBIPROFEN; INFLAMMATION; LUNG; MALE; MICE; NEUTROPHILS; NITRIC OXIDE; PANCREAS; PANCREATITIS; PEROXIDASE; SEPSIS; STOMACH; TIME FACTORS;

EID: 23344450322     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000172093.16033.12     Document Type: Article

References (25)

1. Bhatia M, Brady M, Shokuhi S, Christmas S, Neoptolemos JP, Slavin J: Inflammatory mediators in acute pancreatitis. J Pathol 190:117-125, 2000.
2. Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P, Chevali L: Pathophysiology of acute pancreatitis. Pancreatol 5:132-144, 2005.
3. Bhatia M: Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome. Curr Drug Targets Infl Allergy 1:343-351, 2002.
4. Bhatia M, Moochhala S: Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202:145-156, 2004.
5. Puneet P, Moochhala S, Bhatia M: Chemokines in acute respiratory distress syndrome. Am J Physiol 288:L3-L15, 2005.
6. Takala A, Jousela I, Takkunen O, Kautiainen H, Jansson SE, Orpana A, Karonen SL, Repo H: A prospective study of inflammation markers in patients at risk of indirect acute lung injury. Shack 17:252-257, 2002.
7. del Soldato P, Sorrentino R, Pinto A: NO-aspirins: a class of new anti-inflammatory and antithrombotic agents. Trends Pharmacol Sci 20:319-323, 1999.
8. Wallace JL, Reuter B, Cicala C, McKnight W, Grisham MB, Cirino G: Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology 107:173-179, 1994.
9. Bhatia M, Saluja AK, Hofbauer B, Frossard JL, Lee HS, Castagliuolo I, Wang CC, Gerard N, Pothoulakis C, Steer ML: Role of substance P and the neurokinin I receptor in acute pancreatitis and pancreatitis-associated lung injury. Proc Natl Acad Sci USA 95:4760-1765, 1998.
10. Bhatia M, Slavin S, Cao Y, Basbaum AI, Neoptolemos J: Preprotachykinin-A gene deletion protects mice against acute pancreatitis and associated lung injury. Am J Physiol 284:G830-G836, 2003.
11. Bhatia M, Brady M, Zagorski J, Christmas SE, Camphell F, Neoptolemos JP, Slavin J: Treatment with neutralising antibody against cytokine induced neutrophil chemoattractant (CINC) protects rats against acute pancreatitis associated lung injury. Gut 47:838-844, 2000.
12. Pierre KJ, Tung KK, Nadj H: A new enzymatic kinetic method for the determination of serum and urine amylase. Clin Chem 22:1219, 1976.
13. Leme AS, Lichtenstein A, Arantes-Costa FM, Landucci ECT, Martins MA: Acute lung injury in experimental pancreatitis in rats: pulmonary protective effects of crotapotin and N-acetylcysteine. Shock 18:428-433, 2002.
14. Cuzzocrea S, Genovese T, Mazzon E, Di Paola R, Muia C, Britti D, Salvemini D: Reduction in the development of cerulein-induced acute pancreatitis by treatment with M40401. a new selective superoxide dismutase mimetic. Shock 22:254-261, 2004.
15. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Centorrino T, Ciccolo A, Van de Loo FAJ, Britti D, Caputi AP, Thiemermann C: Inducible nitric oxide synthase-defieient mice exhibit resistance to the acute pancreatitis induced by cerulein. Shock 17:416-422, 2002.
16. Ethridge RT, Chung DH, Slogoff M, Ehlers RA, Hellmich MR, Rajaraman S, Saito H, Uchida T, Evers BM: Cyclooxygenase-2 gene disruption attenuates the severity of acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology 123:1311-1322, 2002.
17. Virlos I, Mazzon E, Serraino I, Di Paola R, Genovese T, Britti D, Thiemerman C, Siriwardena A, Cuzzocrea S: Pyrrolidine dithiocarbamate reduces the severity of cerulein-induced murine acute pancreatitis. Shock 20:544-550, 2003.
18. 2 production and attenuates systemic disease sequelae in experimental pancreatitis. Hepatogastroenterology 50:1159-1162, 2003.
19. Kubes P, Suzuki M, Granger DN: Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651-4655, 1991.
20. Wallace JL, McKnight W, Wilson TL, Del Soldato P, Cirino G: Reduction of shock-induced gastric damage by a nitric oxide-releasing aspirin derivative: role of neutrophils. Am J Physiol 273:G1246-G1251, 1997.
21. Moore PK, Marshall M: Nitric oxide releasing acetaminophen (nitroacetaminophen). Dig Liver Dis 35(suppl 2):S49-S60, 2003.
22. Mariotto S, Menegazzi M, Carcereri de Prati A, Cuzzolin L, Adami A, Suzuki H, Benoni G: Protective effect of NO on gastric lesions and inhibition of expression of gastric inducible NOS by flurbiprofen and its nitro-derivative, nitroflurbiprofen. Br J Pharmacol 116:1713-1714, 1995.
23. Marshall M, Moore PK: Effect of nitric oxide releasing paracetamol and flurbiprofen on cytokine production in human blood. Eur J Pharmacol 483:317-322, 2004.
24. Waisman D, Brod V, Dickstein R, Abramovich A, Rotschild A, Bitterman H: Effects of inhaled nitric oxide on lung injury after intestinal ischemia-reperfusion in rats. Shock 23:150-155, 2005.
25. Chen LW, Hwang B, Chang WJ, Wang JS, Chen JS, Hsu CM: Inducible nitric oxide synthase inhibitor reverses exacerbating effects of Hypertonic saline on lung injury in burn. Shock 22:472-477, 2004.